Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: IL-6 is one of the key factors in the formation of gut tissue resident memory T cells from Naïve T cells.

PLoS pathogens·2026

Same author

IL-6 is one of the key factors in the formation of gut tissue resident memory T cells from Naïve T cells.

PLoS pathogens·2026

Same author

Juvenile Nonhuman Primate Model: The Past, Present, and Future of a Preclinical Model System for Evaluating Development of New Pediatric Drug Formulations.

Journal of medical primatology·2026

Same author

IL-6 is a Key Factor in the Formation of Gut Tissue Resident Memory T Cells from Naïve T cells.

bioRxiv : the preprint server for biology·2025

Same author

Acquisition of quaternary trimer interaction as a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody.

Structure (London, England : 1993)·2025

Same author

A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV.

Structure (London, England : 1993)·2025

Search research articles

Related Experiment Video

Updated: May 4, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Protein-based HIV-1 microbicides.

Barna Dey, Laurel A Lagenaur, Paolo Lusso¹

¹Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bldg. 33, Rm. 1E19A, 33 North Drive, MSC 3210, Bethesda, MD 20892, USA. bdey@mail.nih.gov.

Current HIV Research

|January 3, 2014

Summary

Developing protein-based microbicides offers a promising strategy for preventing HIV-1 transmission. Engineered microbes can deliver these inhibitors, potentially providing long-lasting mucosal protection against the human immunodeficiency virus.

More Related Videos

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Experiment Videos

Last Updated: May 4, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Area of Science:

Microbiology
Virology
Immunology

Background:

HIV/AIDS remains a global health challenge, necessitating diverse prevention strategies beyond vaccines.
Mucosal microbicides are crucial for preventing HIV-1 transmission at the site of initial infection.
Protein-based microbicides represent a novel class of antivirals targeting early viral entry steps.

Purpose of the Study:

To review the current advancements in protein-based microbicides for HIV-1 prevention.
To explore the potential of engineered microbial systems for in vivo microbicide delivery.
To discuss the advantages and challenges associated with protein-based microbicide development.

Main Methods:

Review of in vitro and in vivo studies on protein and peptide-based antiviral agents.
Analysis of pre-clinical and clinical trial data for microbicide candidates.
Evaluation of engineered microbial vectors (bacteria, viruses) for mucosal delivery systems.

Main Results:

Various antiviral molecules show in vitro efficacy against HIV-1.
Protein-based microbicides offer target specificity and minimal systemic absorption.
Engineered Lactobacillus species demonstrate potential for sustained mucosal expression of antiviral proteins.

Conclusions:

Protein-based microbicides are a viable strategy for mucosal HIV-1 prevention.
In vivo expression by commensal microbiota offers a novel approach for prolonged protection.
Further research is needed to optimize formulations and delivery for safe and effective clinical application.